Physician
Ellis Bandt Birkin Kollins & Wong PLLC
Ellis Bandt Birkin Kollins & Wong PLLC was paid $18.10M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 77067, Screening mammography, bilateral, including computer-aided detection — 13% of everything it billed.
33Billing provider infoELLIS BANDT BIRKIN KOLLINS & WONG PLLC
LAS VEGAS, NV 89106
LAS VEGAS, NV 89106
33aNPI1578584678assigned 07/22/2006
33bProvider typeVascular & Interventional Radiology Physician
28Total paid$18.10M
24GClaims198,712
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Vascular & Interventional Radiology Physician providers in Nevada
Rank by total paid#1 of 7
Median peer was paid$40K
This provider vs. median448×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LEBLEU, SHARLEE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,577 | $366K | |
| 2019 | 37,207 | $3.25M | |
| 2020 | 34,168 | $3.11M | |
| 2021 | 43,534 | $4.23M | |
| 2022 | 28,742 | $2.80M | |
| 2023 | 27,592 | $2.67M | |
| 2024incomplete | 19,892 | $1.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 77067 | Screening mammography, bilateral, including computer-aided detection | 13% | 23,152 | 21,531 | $2.36M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 13% | 3,946 | 3,462 | $2.29M |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 8.9% | 9,225 | 8,490 | $1.62M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 7.4% | 5,296 | 4,577 | $1.33M |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 7.1% | 11,753 | 10,835 | $1.29M |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 5.0% | 4,982 | 4,142 | $911K |
| 72141 | 4.7% | 4,920 | 4,645 | $858K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 4.2% | 17,644 | 16,461 | $762K |
| 76770 | 3.9% | 6,838 | 6,317 | $704K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 3.7% | 3,936 | 3,614 | $679K |
| 71046 | Radiologic examination, chest; 2 views | 3.3% | 29,300 | 26,283 | $604K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2.6% | 3,187 | 2,875 | $475K |
80 more codes
| 73221 | 2.4% | 2,552 | $437K | |
| 76536 | 1.8% | 3,625 | $332K | |
| 76830 | Ultrasound, transvaginal | 1.7% | 2,880 | $303K |
| 74178 | 1.4% | 994 | $246K | |
| 76642 | 1.3% | 3,549 | $235K | |
| 72110 | 1.3% | 5,952 | $231K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 1.2% | 2,063 | $213K |
| 77066 | Tomosynthesis, mammo | <1% | 1,361 | $168K |
| 73630 | <1% | 5,098 | $132K | |
| 74183 | <1% | 364 | $132K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 492 | $120K |
| 93970 | <1% | 912 | $111K | |
| 73564 | <1% | 3,190 | $107K | |
| 77065 | Tomosynthesis, mammo | <1% | 1,084 | $97K |
| 71250 | <1% | 973 | $97K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 8,708 | $88K |
| 93925 | <1% | 678 | $85K | |
| 74018 | <1% | 3,301 | $78K | |
| 72050 | <1% | 1,960 | $77K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 900 | $74K |
| 73030 | <1% | 2,637 | $63K | |
| 93976 | <1% | 406 | $59K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 7,115 | $55K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 683 | $54K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 314 | $49K |
| 72146 | <1% | 294 | $46K | |
| 19083 | <1% | 324 | $40K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 948 | $40K |
| 77080 | <1% | 1,576 | $39K | |
| 73718 | <1% | 147 | $38K | |
| 73130 | <1% | 1,343 | $35K | |
| 70486 | <1% | 179 | $32K | |
| 72100 | <1% | 1,033 | $30K | |
| 72072 | <1% | 804 | $26K | |
| 93880 | <1% | 279 | $22K | |
| 77049 | <1% | 58 | $18K | |
| 71271 | <1% | 194 | $17K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 98 | $16K |
| 93971 | <1% | 264 | $15K | |
| 70544 | <1% | 52 | $14K | |
| 78264 | <1% | 57 | $14K | |
| 73502 | <1% | 369 | $12K | |
| 73610 | <1% | 397 | $12K | |
| 72197 | <1% | 48 | $12K | |
| 78227 | <1% | 30 | $10K | |
| 10005 | <1% | 161 | $10K | |
| 72131 | <1% | 75 | $10K | |
| 76641 | <1% | 134 | $10K | |
| 76981 | <1% | 107 | $6K | |
| 72081 | <1% | 147 | $5K | |
| 72158 | <1% | 15 | $5K | |
| 71270 | <1% | 29 | $5K | |
| 75574 | <1% | 13 | $4K | |
| 76882 | <1% | 166 | $4K | |
| J3490 | Unclassified drugs | <1% | 747 | $4K |
| 78226 | <1% | 13 | $3K | |
| 72040 | <1% | 97 | $3K | |
| 78306 | <1% | 12 | $2K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | <1% | 40 | $2K |
| J2805 | Injection, sincalide, 5 micrograms | <1% | 53 | $2K |
| 73110 | <1% | 66 | $2K | |
| 76857 | <1% | 50 | $2K | |
| 73522 | <1% | 46 | $2K | |
| 76885 | <1% | 12 | $2K | |
| 76870 | <1% | 27 | $2K | |
| 73620 | <1% | 62 | $1K | |
| 73562 | <1% | 49 | $1K | |
| 73080 | <1% | 32 | $927.72 | |
| 77072 | <1% | 25 | $594.77 | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | <1% | 12 | $347.06 |
| 71045 | Radiologic examination, chest; single view | <1% | 42 | $267.81 |
| 99443 | <1% | 16 | $22.23 | |
| 7025F | 0% | 672 | $0.00 | |
| G0202 | Screening mammography, bilateral (2-view study of each breast), including computer-aided detection (cad) when performed | 0% | 156 | $0.00 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 330 | $0.00 |
| G9756 | Surgical procedures that included the use of silicone oil | 0% | 86 | $0.00 |
| 3341F | 0% | 40 | $0.00 | |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 297 | $0.00 |
| 77062 | 0% | 170 | $0.00 | |
| 3342F | 0% | 249 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLEBLEU, SHARLEE (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.